News Related to Chronic Inflammatory Disease

Related coverage linked through entity extraction aliases.

Dermatology Trials Surge as Asia-Pacific Region Sees Five-Fold Increase in Research Activity

Mar 08, 2026

More than 16,000 dermatology trials were completed, ongoing, or planned by the end of 2025, with the Asia-Pacific region experiencing a nearly five-fold increase over the past decade. The field now accounts for around 8,000 trials in Asia-Pacific alone, matching North America and Europe combined.

Sanofi Gains FDA Approval for Dupixent AFRS Indication and EU Opinion for Sleeping Sickness Drug

Feb 28, 2026

Sanofi receives FDA approval for Dupixent to treat allergic fungal rhinosinusitis and gains European endorsement for Acoziborole Winthrop as a sleeping sickness treatment, which will be donated to WHO.